Nomura ADR slides after profit miss on impairments and Europe losses
Nomura Holdings’ ADR fell as investors digested a fresh quarterly earnings miss driven by impairment charges and a loss in its Europe business. The slide follows the company’s FY2025/26 results release and management Q&A on April 24, 2026, which detailed writedowns including a roughly ¥12 billion impairment tied to a forestry-related investment.
1. What’s moving the stock
Nomura Holdings, Inc. (NMR) is trading lower as the market continues to reprice the shares after the company’s latest quarterly results showed profit coming in below expectations. The miss was tied to writedowns on investments—most notably at a research affiliate—alongside a loss in the firm’s Europe business, which outweighed otherwise steadier performance in other operating lines. (bloomberg.com)
2. Key earnings takeaway investors are reacting to
The FY2025/26 fourth-quarter update released after the market close on April 24, 2026 highlighted impairment items that became the focal point for investors. In the conference call Q&A, Nomura’s CFO addressed an impairment loss of approximately ¥12 billion related to a forestry-linked asset management investment, reinforcing the narrative that one-time charges were a meaningful drag on the quarter’s headline profitability. (nomuraholdings.com)
3. Why the reaction is spilling into today’s U.S. ADR trading
Because Nomura is Japan-listed with a U.S.-traded ADR, the U.S. session often reflects delayed digestion of Tokyo’s earnings reaction and follow-through positioning after new disclosures. With the earnings miss framed around impairments and Europe weakness, incremental sellers are treating the print as a catalyst to reduce exposure, keeping pressure on the ADR in the days immediately following the results. (bloomberg.com)